Smith+Nephew Cuts 2026 Outlook Amid Orthopedics Decline
Smith+Nephew has lowered its full-year 2026 revenue guidance from 6% to 4% due to a disappointing Q2, with revenue growing only 1.6% and orthopedics experiencing a decline. Despite this, the company is maintaining its profit guidance by implementing additional efficiency savings from its 12-Point …